查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765150

全球周邊血管設備市場

Peripheral Vascular Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球周邊血管設備市場規模將達到 160 億美元

全球周邊血管器械市場規模預計在2024年為127億美元，到2030年將達到160億美元，在2024-2030年的分析期內，複合年成長率為4.0%。血管成形術支架是本報告分析的細分市場之一，預計其複合年成長率為4.6%，到分析期結束時規模將達到91億美元。血管成形術球囊細分市場在分析期間的複合年成長率預計為3.6%。

美國市場預計將達到 34 億美元，中國市場複合年成長率將達到 3.6%

美國周邊血管器械市場規模預計2024年達到34億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到25億美元，在2024-2030年的分析期間內，複合年成長率為3.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.7%和3.3%。在歐洲，預計德國市場的複合年成長率為2.8%。

全球周邊血管設備市場－主要趨勢與促進因素摘要

為什麼周邊血管裝置對現代醫學至關重要？

周邊血管裝置是診斷和治療影響周邊血管（例如心臟和腦外的動脈、靜脈和淋巴管）疾病的重要工具。這些裝置包括支架、導管、球囊、過濾器等，用於治療周邊動脈疾病(PAD)、深層靜脈栓塞症血栓形成 (DVT) 和慢性靜脈功能不全 (CVI) 等疾病。這些裝置的重要性在於它們能夠恢復正常血流、降低併發症風險並改善患者預後。例如，血管成形術球囊和支架可用於打通狹窄或阻塞的動脈，以促進血液循環並防止組織損傷。使用這些裝置的微創手術的發展徹底改變了血管外科手術，縮短了復健時間並提高了患者的生活品質。

技術進步如何影響周邊血管裝置？

技術進步顯著提高了周邊血管裝置的功能和功效。藥物釋放型洗脫支架（可釋放藥物以防止血管再阻塞）和生物可吸收支架（在恢復血流後逐漸溶解）等創新療法是血管治療的重要突破。此外，血管內超音波（IVUS）和光同調斷層掃瞄（OCT）等影像技術的進步提高了支架放置的準確性和血管狀態的評估。形狀記憶合金和生物相容性聚合物等先進材料的融合提高了這些裝置的耐用性和性能。此外，結合藥物輸送和機械支撐等多種功能的混合裝置的開發擴大了臨床醫生可用的治療選擇。這些技術進步使治療更安全、更有效、更侵入性。

周邊血管裝置的主要應用有哪些？

周邊血管裝置在各醫學學科中有著廣泛的應用。在介入性心臟病學中，這些裝置用於治療周邊動脈疾病 (PAD)，其特徵是周邊動脈（通常發生在腿部）變窄，導致疼痛和行動不便。使用球囊和支架的血管內治療有助於重新打開這些動脈，恢復血流並緩解症狀。在血管外科手術中，移植物和血管內動脈瘤修復 (EVAR) 系統等裝置對於治療動脈瘤至關重要。動脈瘤是血管壁上的凸起或薄弱區域，如果處理不當可能會破裂。此外，周邊血管裝置對於治療深部靜脈栓塞 (DVT) 等靜脈疾病至關重要，而血栓切除裝置和過濾器可以預防肺動脈栓塞等危及生命的併發症。這些裝置對各種血管疾病的多功能性和有效性凸顯了它們在現代醫療實踐中的重要性。

哪些因素推動了周邊血管設備市場的成長？

周邊血管器械市場的成長受多種因素驅動。其中一個關鍵促進因素是心血管疾病以及糖尿病和高血壓等生活方式相關疾病的盛行率不斷上升，這些疾病增加了周邊血管疾病的風險。技術進步提高了血管器械的安全性和有效性，擴大了可治療疾病的範圍並改善了患者的預後，也推動了市場的成長。此外，全球人口老化也促進了市場擴張，因為老年人更容易患血管疾病。與傳統手術相比，微創手術恢復時間更短、併發症更少，因此市場對微創手術的需求日益成長，這進一步推動了這些器械的普及。此外，新興市場醫療支出的增加和先進醫療技術的普及也創造了新的成長機會。這些因素共同推動了周邊血管器械市場走上強勁的成長軌道，而這主要得益於市場對創新有效的血管治療的持續需求。

部分

設備類型（血管成形術支架、血管成形術用氣球、EVAR血管支架、導管、斑塊改造設備、血流動力學改變設備、下腔靜脈濾器、其他設備類型）

受訪公司範例

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular SLU
  • Medtronic PLC
  • Terumo Corporation

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13924

Global Peripheral Vascular Devices Market to Reach US$16.0 Billion by 2030

The global market for Peripheral Vascular Devices estimated at US$12.7 Billion in the year 2024, is expected to reach US$16.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of the analysis period. Growth in the Angioplasty Balloon segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 3.6% CAGR

The Peripheral Vascular Devices market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Peripheral Vascular Devices Market - Key Trends and Drivers Summarized

Why Are Peripheral Vascular Devices Essential in Modern Medicine?

Peripheral vascular devices are critical tools in the diagnosis and treatment of diseases affecting the peripheral blood vessels, including arteries, veins, and lymphatic vessels outside of the heart and brain. These devices, which include stents, catheters, balloons, and filters, are used to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). The importance of these devices lies in their ability to restore proper blood flow, reduce the risk of complications, and improve patient outcomes. For instance, angioplasty balloons and stents are utilized to open narrowed or blocked arteries, enhancing blood circulation and preventing tissue damage. The development of minimally invasive techniques involving these devices has revolutionized vascular surgery, reducing recovery times and improving the quality of life for patients.

How Are Technological Advancements Shaping Peripheral Vascular Devices?

Technological advancements are significantly enhancing the functionality and efficacy of peripheral vascular devices. Innovations such as drug-eluting stents, which release medication to prevent restenosis, and bioresorbable stents, which gradually dissolve after restoring blood flow, represent significant breakthroughs in vascular treatment. Additionally, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are improving the precision of device placement and the assessment of vascular conditions. The integration of advanced materials, like shape-memory alloys and biocompatible polymers, is enhancing the durability and performance of these devices. Furthermore, the development of hybrid devices that combine multiple functions, such as drug delivery and mechanical support, is expanding the therapeutic options available to clinicians. These technological strides are making treatments safer, more effective, and less invasive.

What Are the Key Applications of Peripheral Vascular Devices?

Peripheral vascular devices have a wide range of applications across various medical disciplines. In interventional cardiology, these devices are used to treat PAD, which is characterized by the narrowing of peripheral arteries, typically in the legs, leading to pain and mobility issues. Endovascular treatments using balloons and stents help to reopen these arteries, restoring blood flow and alleviating symptoms. In vascular surgery, devices like grafts and endovascular aneurysm repair (EVAR) systems are essential for treating aneurysms, which are bulging or weakened areas in the vessel walls that can rupture if not managed properly. Additionally, peripheral vascular devices are crucial in managing venous diseases, such as DVT, where clot removal devices and filters prevent life-threatening complications like pulmonary embolism. The versatility and effectiveness of these devices in addressing various vascular conditions highlight their importance in contemporary medical practice.

What Factors Are Driving the Growth in the Peripheral Vascular Devices Market?

The growth in the peripheral vascular devices market is driven by several factors. One significant driver is the increasing prevalence of cardiovascular diseases and lifestyle-related conditions such as diabetes and hypertension, which heighten the risk of peripheral vascular disorders. Technological advancements that enhance the safety and efficacy of vascular devices are also propelling market growth, as they expand the range of treatable conditions and improve patient outcomes. Additionally, the aging global population is contributing to market expansion, as older adults are more susceptible to vascular diseases. The rising demand for minimally invasive procedures, which offer shorter recovery times and fewer complications compared to traditional surgeries, is further boosting the adoption of these devices. Moreover, increasing healthcare expenditure and improved access to advanced medical technologies in emerging markets are creating new opportunities for growth. These factors collectively ensure a robust growth trajectory for the peripheral vascular devices market, driven by the ongoing need for innovative and effective vascular treatments.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Other Device Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular S.L.U
  • Medtronic PLC
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Vascular Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Peripheral Artery Disease (PAD) Propels Growth in Peripheral Vascular Devices Market
    • Advances in Minimally Invasive Techniques Strengthen Business Case for Peripheral Vascular Devices
    • Increasing Adoption of Drug-Eluting Stents and Balloons Drives Market Growth
    • Expansion of Endovascular Procedures Generates Market Opportunities
    • Technological Innovations in Imaging and Navigation Systems Enhance Market Potential
    • Growing Geriatric Population Sustains Demand for Peripheral Vascular Interventions
    • Increasing Focus on Patient Safety and Outcomes Spurs Market Adoption
    • Development of Biodegradable and Bioabsorbable Devices Expands Addressable Market
    • Growing Awareness of Peripheral Vascular Diseases Spurs Market Demand
    • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
    • Increasing Investments in Healthcare Infrastructure Drive Adoption of Peripheral Vascular Devices
    • Expansion of Peripheral Vascular Device Applications in Emerging Markets Propels Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Vascular Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Vascular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Peripheral Vascular Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Angioplasty Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Angioplasty Balloon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Angioplasty Balloon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Angioplasty Balloon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EVAR Stent Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EVAR Stent Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for EVAR Stent Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Inferior Vena Cava Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • CHINA
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Peripheral Vascular Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Peripheral Vascular Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 47: France Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: France Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: France 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Germany 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 53: Italy Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Italy Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Italy 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: UK 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of Europe 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of World Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of World 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030

IV. COMPETITION